L & S Advisors Inc Bridge Bio Pharma, Inc. Transaction History
L & S Advisors Inc
- $895 Million
- Q3 2025
A detailed history of L & S Advisors Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, L & S Advisors Inc holds 16,893 shares of BBIO stock, worth $1.04 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
16,893Holding current value
$1.04 Million% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
421Shares Held
188MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.15 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$1.04 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$820 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$769 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$573 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.16B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...